Back to News
Market Impact: 0.25
Celularity Faces Nasdaq Compliance Issue Over Delayed 10-Q Filings
Source: Nasdaq
Legal & LitigationCompany FundamentalsRegulation & Legislation
Celularity Inc. (CELU) received a Nasdaq notification on Aug. 21, 2026 for non-compliance with Listing Rule 5250(c)(1) stemming from delayed 10-Q filings. The update flags ongoing disclosure/timeliness issues that can pressure investor confidence even though no financial results were reported.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.25
Ticker Sentiment
CELU-0.55
More News
- ‘How many canaries have we killed in the coal mine?’ — Wall Street debates if the latest AI bubble warnings are another head fake or the real thing
- Ericsson’s organic sales rise 7% as it merges its two Asian units
- Bending Spoons wants to revive software castoffs. Berkshire is backing the plan
- TSMC posts a sixth straight record profit but turns cautious on 2027
- States sue OpenAI, saying it gives life to ‘cyberhacking agents’ while ChatGPT hurts children and deceives adults
- Trump faces bipartisan backlash over Russia sanctions waiver
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- How to Search Earnings Call Transcripts With AI
- What a Concept From Nature Tells Us About How C-Suite Executives Actually Think About AI